These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 22381151

  • 1. What factors may influence psychological well being at three months and one year post BRCA genetic result disclosure?
    Bosch N, Junyent N, Gadea N, Brunet J, Ramon y Cajal T, Torres A, Graña B, Velasco A, Darder E, Mensa I, Balmaña J.
    Breast; 2012 Dec; 21(6):755-60. PubMed ID: 22381151
    [Abstract] [Full Text] [Related]

  • 2. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
    van Oostrom I, Meijers-Heijboer H, Lodder LN, Duivenvoorden HJ, van Gool AR, Seynaeve C, van der Meer CA, Klijn JG, van Geel BN, Burger CW, Wladimiroff JW, Tibben A.
    J Clin Oncol; 2003 Oct 15; 21(20):3867-74. PubMed ID: 14551306
    [Abstract] [Full Text] [Related]

  • 3. Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes.
    Manchanda R, Burnell M, Gaba F, Desai R, Wardle J, Gessler S, Side L, Sanderson S, Loggenberg K, Brady AF, Dorkins H, Wallis Y, Chapman C, Jacobs C, Legood R, Beller U, Tomlinson I, Menon U, Jacobs I.
    BJOG; 2020 Feb 15; 127(3):364-375. PubMed ID: 31507061
    [Abstract] [Full Text] [Related]

  • 4. Psychological impact of receiving a BRCA1/BRCA2 test result.
    Lodder L, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Duivenvoorden HJ, Tibben A, Wagner A, van der Meer CA, van den Ouweland AM, Niermeijer MF.
    Am J Med Genet; 2001 Jan 01; 98(1):15-24. PubMed ID: 11426450
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
    Fortuny D, Balmaña J, Graña B, Torres A, Ramón y Cajal T, Darder E, Gadea N, Velasco A, López C, Sanz J, Alonso C, Brunet J.
    Hum Reprod; 2009 Apr 01; 24(4):1000-6. PubMed ID: 19112076
    [Abstract] [Full Text] [Related]

  • 9. How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults.
    Bradbury AR, Dignam JJ, Ibe CN, Auh SL, Hlubocky FJ, Cummings SA, White M, Olopade OI, Daugherty CK.
    J Clin Oncol; 2007 Aug 20; 25(24):3705-11. PubMed ID: 17704419
    [Abstract] [Full Text] [Related]

  • 10. Psychological distress and quality of life associated with genetic testing for breast cancer risk.
    Smith AW, Dougall AL, Posluszny DM, Somers TJ, Rubinstein WS, Baum A.
    Psychooncology; 2008 Aug 20; 17(8):767-73. PubMed ID: 17992698
    [Abstract] [Full Text] [Related]

  • 11. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
    van Dijk S, Timmermans DR, Meijers-Heijboer H, Tibben A, van Asperen CJ, Otten W.
    J Clin Oncol; 2006 Aug 01; 24(22):3672-7. PubMed ID: 16877736
    [Abstract] [Full Text] [Related]

  • 12. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
    Kauff ND, Mitra N, Robson ME, Hurley KE, Chuai S, Goldfrank D, Wadsworth E, Lee J, Cigler T, Borgen PI, Norton L, Barakat RR, Offit K.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1382-4. PubMed ID: 16174860
    [Abstract] [Full Text] [Related]

  • 13. Identification of patients at high risk of psychological distress after BRCA1 genetic testing.
    Ertmański S, Metcalfe K, Trempała J, Głowacka MD, Lubiński J, Narod SA, Gronwald J.
    Genet Test Mol Biomarkers; 2009 Jun 21; 13(3):325-30. PubMed ID: 19405874
    [Abstract] [Full Text] [Related]

  • 14. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT.
    Gynecol Oncol; 2005 May 21; 97(2):457-67. PubMed ID: 15863145
    [Abstract] [Full Text] [Related]

  • 15. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC, Northouse L, Pierce P, Milliron KJ, Liu G, Merajver SD.
    Oncol Nurs Forum; 2011 Sep 21; 38(5):572-81. PubMed ID: 21875844
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening.
    Metcalfe KA, Mian N, Enmore M, Poll A, Llacuachaqui M, Nanda S, Sun P, Hughes KS, Narod SA.
    Breast Cancer Res Treat; 2012 Jun 21; 133(2):735-40. PubMed ID: 22240989
    [Abstract] [Full Text] [Related]

  • 20. Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study.
    Brandberg Y, Sandelin K, Erikson S, Jurell G, Liljegren A, Lindblom A, Lindén A, von Wachenfeldt A, Wickman M, Arver B.
    J Clin Oncol; 2008 Aug 20; 26(24):3943-9. PubMed ID: 18711183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.